Blog
0
A Poem on Cancer’s Breaking News
0

Breaking News:Kate Middleton, the Princess of Wales at age 42 has cancer.King Charles, age 75, also has cancer.Cancer, an equal opportunity disease.Class, ...

0
Birthdays Come With Tears After Cancer
0

Grandson wonders why she cries at birthdays He thinks it’s “the things”Were the balloons not pretty enough?Was the cake not good?She hugs him hard, breathes ...

0
Living With Breast Cancer
0

Living With Cancer What do you do when you hear the newsAnd will others be there for youWill they give you support with arms open wideWill they say they ...

0
My Approach to Figuring Out Life After Cancer
0

In the past month, my wife and I have moved across the country and left behind everything I knew, after living in New York all my life. We then found water ...

0
Padcev-Keytruda Combo Nearly Doubles Survival Time in Bladder Cancer
0

“ there are other options that potentially may be more effective and even better tolerated and could be offered to a wider variety of patients,” an expert ...

0
Columvi Plus GemOx May Improve Survival in R/R DLBCL
0

Patients lived longer when treated with Columvi and GemOx when compared with Rituxan (rituximab) and GemOx. Treatment with the bispecific antibody ...

0
The Sudden Twists and Turns of Cancer
0

It is a bright spring day, tomorrow the weather is forecasted to take a turn for the worse. Cold temperatures, snow and wind are on the way. You would never ...

0
Dickey Betts Died, ‘Shopaholic’ Author Announces Cancer Diagnosis and More
0

Sophie Kinsella, author of "Shopaholic," announced having brain cancer after her children adjusted to their "new normal."“Shopaholic” author was diagnosed ...

0
Cancer Taught Me that Family Matters Most
0

YOUWhen You were born, time stood still.How blessed we were to have this little miracle enter our lives.Small, pink and fragile, could we do a good job? ...

0
FDA Approves Alecensa for ALK-Positive NSCLC
0

The Food and Drug Administration (FDA) has approved Alecensa (alectinib) for the treatment of patients with ALK-positive non-small cell lung cancer (NSCLC) ...

0
Novel IGSF8 Plus Keytruda Evaluated in Phase 1 Trial for Solid Tumors
0

A phase 1 trial is evaluating the safety and tolerability of two immune checkpoint inhibitors in patients with advanced solid tumors. A combination of a ...

0
ADC FG-3246 May Show Promise in Advanced Prostate Cancer
0

Findings from a preliminary trial evaluating a novel antibody-drug conjugate demonstrates benefits in patients with advanced prostate cancer.Treatment with ...

CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart